A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Istanbul Medical Journal Pub Date : 2023-05-31 DOI:10.4274/imj.galenos.2023.66742
I. Serin, M. Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, A. Baştürk, M. Aras, Sinan Demircioğlu, B. Turgut, M. Merter, S. Kabukçu Hacıoğlu, M. Bagci, M. Albayrak, S. Korkmaz, M. Erkurt, M. Dal, F. Ersoy Dursun, A. Tombak, İ. Aydoğdu, T. Ulaş, F. Altuntaş
{"title":"A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera","authors":"I. Serin, M. Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, A. Baştürk, M. Aras, Sinan Demircioğlu, B. Turgut, M. Merter, S. Kabukçu Hacıoğlu, M. Bagci, M. Albayrak, S. Korkmaz, M. Erkurt, M. Dal, F. Ersoy Dursun, A. Tombak, İ. Aydoğdu, T. Ulaş, F. Altuntaş","doi":"10.4274/imj.galenos.2023.66742","DOIUrl":null,"url":null,"abstract":"Cite this article as: Serin İ, Doğu MH, Ekinci Ö, Akgün Çağlıyan G, Baştürk A, Aras MR, Demircioğlu S, Turgut B, Merter M, Kabukçu Hacıoğlu S, Bağcı M, Albayrak M, Korkmaz S, Erkurt MA, Dal MS, Ersoy Dursun F, Tombak A, Aydoğdu İ, Ulaş T, Altuntaş F. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera. İstanbul Med J 2023; 24(2): 120-5. 1University of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 2İstinye University, Liv Hospital Ulus, Clinic of Hematology, İstanbul, Turkey 3University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Clinic of Hematology, Diyarbakır, Turkey 4Pamukkale University Faculty of Medicine, Department of Hematology, Denizli, Turkey 5Medicana International İstanbul Hospital, İstanbul, Turkey 6University of Health Sciences Turkey, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 7Necmettin Erbakan University, Meram Faculty of Medicine, Department of Hematology, Konya, Turkey 8Namık Kemal University Faculty of Medicine, Department of Hematology, Tekirdağ, Turkey 9Fırat University Faculty of Medicine, Department of Hematology, Elazığ, Turkey 10Selçuk University Faculty of Medicine, Department of Hematology, Konya, Turkey 11University of Health Sciences Turkey, Kayseri City Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Kayseri, Turkey 12İnönü University Faculty of Medicine, Department of Hematology, Malatya, Turkey 13University of Health Sciences Turkey, Ankara Oncology Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Ankara, Turkey 14İstanbul Medeniyet University, Göztepe Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 15Mersin University Faculty of Medicine, Department of Hematology, Mersin, Turkey 16Manisa Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey 17Near East University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Lefkoşa, Cyprus 18Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Istanbul Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/imj.galenos.2023.66742","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 1

Abstract

Cite this article as: Serin İ, Doğu MH, Ekinci Ö, Akgün Çağlıyan G, Baştürk A, Aras MR, Demircioğlu S, Turgut B, Merter M, Kabukçu Hacıoğlu S, Bağcı M, Albayrak M, Korkmaz S, Erkurt MA, Dal MS, Ersoy Dursun F, Tombak A, Aydoğdu İ, Ulaş T, Altuntaş F. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera. İstanbul Med J 2023; 24(2): 120-5. 1University of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 2İstinye University, Liv Hospital Ulus, Clinic of Hematology, İstanbul, Turkey 3University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Clinic of Hematology, Diyarbakır, Turkey 4Pamukkale University Faculty of Medicine, Department of Hematology, Denizli, Turkey 5Medicana International İstanbul Hospital, İstanbul, Turkey 6University of Health Sciences Turkey, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 7Necmettin Erbakan University, Meram Faculty of Medicine, Department of Hematology, Konya, Turkey 8Namık Kemal University Faculty of Medicine, Department of Hematology, Tekirdağ, Turkey 9Fırat University Faculty of Medicine, Department of Hematology, Elazığ, Turkey 10Selçuk University Faculty of Medicine, Department of Hematology, Konya, Turkey 11University of Health Sciences Turkey, Kayseri City Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Kayseri, Turkey 12İnönü University Faculty of Medicine, Department of Hematology, Malatya, Turkey 13University of Health Sciences Turkey, Ankara Oncology Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Ankara, Turkey 14İstanbul Medeniyet University, Göztepe Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 15Mersin University Faculty of Medicine, Department of Hematology, Mersin, Turkey 16Manisa Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey 17Near East University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Lefkoşa, Cyprus 18Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ruxolitinib治疗维拉红细胞增多症的土耳其真实体验
引用本文为:Serinï,Doğu MH,EkinciÖ,AkgünÇağlıyan G,Baştürk a,Aras MR,Demircioğlu S,Turgut B,Merter M,Kabukçu Hacıoğlu S,BağcıM,Albayrak M,Korkmaz S,Erkurt MA,Dal MS,Ersoy Dursun F,Tombak a,Aydoğduï,Ulaşt,AltuntaşF.Ruxolitinib在土耳其的真实体验维拉红细胞增多症。伊斯坦布尔医学杂志2023;24(2):120-5。1土耳其健康科学大学,伊斯坦布尔培训与研究医院,血液学诊所,土耳其伊斯坦布尔2伊斯坦布尔耶大学,利夫医院,Ulus,血液学门诊,土耳其伊斯坦布尔3土耳其卫生科学大学,Gazi Yaşargil培训与研究院,血液学临床,土耳其迪亚巴克尔4帕穆卡莱大学医学院血液学系,Denizli,土耳其5医学院伊斯坦布尔国际医院,土耳其伊斯坦布尔6土耳其健康科学大学,DışkapıYıldırım Beyazıt培训和研究医院,血液学诊所,土耳其安卡拉7 Necmettin Erbakan大学,Meram医学院,血液学系,土耳其科尼亚,土耳其9Fırat大学医学院血液系,Elazığ,土耳其13土耳其卫生科学大学,安卡拉肿瘤培训和研究医院,血液学和单采诊所,土耳其安卡拉14伊斯坦布尔梅德尼耶大学,Göztepe培训和研究中心,血液学诊所,土耳其伊斯坦布尔15梅尔辛大学医学院,血液学系,梅尔辛,土耳其16 Manisa Celal Bayar大学医学院血液系,土耳其马尼萨17近东大学医学院内科血液系,塞浦路斯Lefkoşa 18安卡拉Yıldırım Beyazıt大学医学院
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Istanbul Medical Journal
Istanbul Medical Journal MEDICINE, GENERAL & INTERNAL-
CiteScore
0.30
自引率
0.00%
发文量
46
审稿时长
18 weeks
期刊最新文献
Concordance between Patient and Physician Predictions of PCR Results and Predictive Capacity of Presenting Complaints in Suspected Infectious Diseases Evaluation of the Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index in Ankylosing Spondylitis Patients Hyperkalemia: A Cause of Non-adherence to Renin- Angiotensin-Aldosterone System Inhibitors in Chronic Kidney Disease: A Retrospective Study Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus Predictive Value of Neutrophil/Lymphocyte Ratio for Developing Acute Renal Failure in Patients with Sepsis Using Colistin in Intensive Care Units
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1